Information Links
Mims
Main Navigation
Drugs
Conditions
News and resourcesLicence Changes & Product Updates
Reduce insulin doses carefully when starting GLP-1 agonists, MHRA advises
A careful stepwise approach is needed when reducing...
Prescribers advised not to use newer anticoagulants in patients with antiphospholipid syndrome
Direct-acting oral anticoagulants (DOACs) should not...
NICE recommends new triple therapy option for diabetes
Ertugliflozin (Steglatro) can now be prescribed routinely...
First oral hypoglycaemic licensed for add-on therapy in type I diabetes
The SGLT2 inhibitor dapagliflozin (Forxiga) can now...
Trimovate available to prescribe again
GPs can prescribe the steroid/antibiotic cream Trimovate...
Teething products containing lidocaine to become 'P' medicines
All oral lidocaine-containing preparations indicated...
Long-acting anticholinergic licensed for childhood asthma
Spiriva Respimat (tiotropium) is now licensed for use...
Capsule inhalation warning for tiotropium inhaler
Train patients prescribed Braltus (tiotropium) in the...
PCSK9 inhibitor licensed for risk reduction in established cardiovascular disease
Repatha (evolocumab) can now be prescribed to reduce...
Diabetes test strips recalled
Patients with diabetes who use the Accu-Chek Aviva...
MIMS Clinics
Prescribing news and resources for key therapeutic areas, collated by the MIMS editors.
